Coccidioidomycosis historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Coccidioidomycosis}}
{{Coccidioidomycosis}}
{{CMG}}
{{CMG}}; {{AE}} {{ADG}}
==Overview==


==Historical Perspective==
==Historical Perspective==

Revision as of 17:25, 8 March 2017

Coccidioidomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Coccidioides immitis
Coccidioides posadasii

Differentiating Coccidioidomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Coccidioidomycosis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Coccidioidomycosis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Coccidioidomycosis historical perspective

CDC on Coccidioidomycosis historical perspective

Coccidioidomycosis historical perspective in the news

Blogs on Coccidioidomycosis historical perspective

Directions to Hospitals Treating Coccidioidomycosis

Risk calculators and risk factors for Coccidioidomycosis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Historical Perspective

  • In 1892, Alejandro Posadas (a medical student) along with his mentor, Robert Wernicke discovered coccidomycosis .
  • In 1896, Emmet Rixford and T. Caspar Gilchrist coined the term coccidomycosis (resembling Coccidia), they also grouped coccidomycosis under parasitic family.
  • In 1900, William Ophüls and Herbert C. Moffitt described its dimorphic nature and defined it as a fungal etiology.
  • In 1914, Cooke discovered coccidioidin skin test using precipitin reaction for the first time in diagnosing coccidomycosis.

Biological Warfare

C. immitis was investigated by the United States during the 1950s and 1960s as a potential biological weapon. The Cash strain received the military symbol OC, and original hopes were for its use as an incapacitant. As medical epidemiology later made clear, OC would have lethal effects on several segments of the population, so it was later considered a lethal agent. It was never standardized, around beyond a few field trials, it was never weaponized. Most military work on OC was on vaccines by the mid-1960s.

References

Template:WH Template:WS